Search Results
Dr. O'Connor on the Role of Obinutuzumab in Follicular Lymphoma
Upfront Therapy Strategies in Follicular Lymphoma
Dr. O'Connor on Recent FDA Approvals in MCL
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial
Robert E. Marcus, MD: GALLIUM Study of Obinutuzumab in Untreated Follicular Lymphoma
Deciding on Rituximab Versus Obinutuzumab in Follicular Lymphoma
Dr. O'Connor on Treatment Options Following Ibrutinib Progression in MCL
Dr. Epperla on FDA Approval of Frontline Obinutuzumab in Follicular Lymphoma
Dr. Younes on Atezolizumab, Obinutuzumab, and Bendamustine in Follicular Lymphoma
Is obinutuzumab our key to improving the treatment of FL?
Maintenance Therapy in Follicular Lymphoma
Debate: Best upfront therapy for advanced follicular lymphoma - Obinutuzumab-based therapy
